CN104116839B - A kind of Chinese medicine treating pelvic inflammatory disease - Google Patents

A kind of Chinese medicine treating pelvic inflammatory disease Download PDF

Info

Publication number
CN104116839B
CN104116839B CN201410398490.5A CN201410398490A CN104116839B CN 104116839 B CN104116839 B CN 104116839B CN 201410398490 A CN201410398490 A CN 201410398490A CN 104116839 B CN104116839 B CN 104116839B
Authority
CN
China
Prior art keywords
parts
chinese medicine
radix
inflammatory disease
pelvic inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410398490.5A
Other languages
Chinese (zh)
Other versions
CN104116839A (en
Inventor
刘雪梅
王立中
张敏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heilongjiang Tianchen Pharmaceutical Co.,Ltd.
Original Assignee
刘雪梅
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 刘雪梅 filed Critical 刘雪梅
Priority to CN201410398490.5A priority Critical patent/CN104116839B/en
Publication of CN104116839A publication Critical patent/CN104116839A/en
Application granted granted Critical
Publication of CN104116839B publication Critical patent/CN104116839B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The present invention relates to a kind of Chinese medicine treating pelvic inflammatory disease, the medicine including following parts by weight is prepared from: 15 30 parts of the Radix Rehmanniae, 38 parts of Poria, Medulla Tetrapanacis 15 25 parts, Spica Prunellae 47 parts, Radix Scutellariae 20 30 parts, Radix Paeoniae Rubra 6 10 parts, the Radix Aucklandiae 10 15 parts.The present invention provides a kind of instant effect, and cure rate is high, the Chinese medicine of the treatment treatment pelvic inflammatory disease having no side effect.

Description

A kind of Chinese medicine treating pelvic inflammatory disease
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of Chinese medicine treating pelvic inflammatory disease.
Background technology
Pelvic inflammatory disease i.e. pelvic inflammation refer to female pelvic cavity genitals, periuterine connective tissue and Pelvic peritoneal inflammation.Chronic pelvic inflammation is often that acute stages treated is the most thoroughly delayed, Its disease time is long, and the state of an illness is more obstinate.Antibacterial retrograde infection, is arrived by uterus, fallopian tube Reach pelvic cavity.But in actual life, not all women can suffer from pelvic inflammatory disease, morbidity Simply minority.This is because female reproductive system has a natural defense function, under normal circumstances, The invasion of antibacterial can be resisted, only decline when the resistance of body, or due to other reasons maid When the natural defense function of property is destroyed, just can cause the generation of pelvic inflammatory disease.Under its symptom is Stomachache, heating, vaginal secretions increase, and suffer from abdominal pain as persistence, movable or sexual intercourse postemphasis. Shiver with cold, high heat, headache, inappetence can be had if being in a bad way.Menstrual phase is sent out patient and be may occur in which Menorrhagia, menostaxis, if pelvic inflammatory disease is wrapped to form pelvic abscess and can cause local compression disease Shape, compressing bladder may occur in which frequent micturition, dysurea, dysuria;After compressing rectum may occur in which pain in the abdomen Heavily wait rectum symptom.Acute pelvic inflammatory disease develop further can cause general peritonitis, septicemia, Septic shock, severe patient can threat to life.
The various neuropathic condition that treatment pelvic inflammatory disease causes, generally comprise Drug therapy and local is controlled Treat, this type of therapy in certain degree can cure diseases, but treatment after disease easily recur, Additionally, the medicine of Drug therapy is mostly Western medicine, Western medicine side effect is big, and many patients are to Western medicine Having untoward reaction, the therapeutic effect for Cervicitis is the most notable.
Summary of the invention
For the deficiencies in the prior art, the present invention provides a kind of instant effect, and cure rate is high, nontoxic The Chinese medicine of the treatment treatment pelvic inflammatory disease of side effect.
The technical scheme is that and be achieved in that: a kind of Chinese medicine treating pelvic inflammatory disease, including with The medicine of lower parts by weight is prepared from: Radix Rehmanniae 15-30 part, Poria 3-8 part, Medulla Tetrapanacis 15-25 Part, Spica Prunellae 4-7 part, Radix Scutellariae 20-30 part, Radix Paeoniae Rubra 6-10 part, Radix Aucklandiae 10-15 part.
Technical scheme can be achieved in that
A kind of Chinese medicine treating pelvic inflammatory disease, the medicine including following parts by weight is prepared from: bag The medicine including following parts by weight is prepared from: 26 parts of the Radix Rehmanniae, 6 parts of Poria, Medulla Tetrapanacis 20 parts, Spica Prunellae 6 parts, Radix Scutellariae 25 parts, Radix Paeoniae Rubra 8 parts, the Radix Aucklandiae 13 parts.
The preparation method of Chinese medicine of the present invention is by the medicinal material drying of its each component, is ground into fine powder, Facing-up is uniform, makes the watered pill (every watered pill is containing 0.1 gram of Chinese medicine).
The instructions of taking of the Chinese medicine of the present invention is: oral three times a day, early, middle evening service once, Warm water is sent down, and the intake of every day is 60 (6 grams), within one month, is a course for the treatment of, 5 days are withdrawn between each course for the treatment of.
The course for the treatment of: 30 days be a course for the treatment of, the 1-5 course for the treatment of need to be taken.
The pharmacology of each concrete ingredient is as follows:
The Radix Rehmanniae: sweet, cold.GUIXIN, liver, kidney channel.Function cures mainly: have clearing away heat and cooling blood effect Join the army blood for warming febrile disease, high fever coma, xerostomia crimson tongue.
Poria: sweet, light is flat.GUIXIN, enter lung, stomach warp;Function cures mainly: promoting diuresis to eliminate damp pathogen, And mild in medicine property and, diuretic and do not hinder healthy energy.
Medulla Tetrapanacis: sweet in the mouth;Light, cold nature, stimulates the menstrual flow and closes, treat jaundice, eliminating carbuncle cellulitis, profit nose carbuncle.
Spica Prunellae: cold in nature, sweet in the mouth, hardship pungent, micro-.Have and let out clearly liver-fire, mass dissipating and swelling eliminating, clear Thermal detoxification, expelling phlegm for arresting cough, effect of cooling blood for hemostasis.
Radix Scutellariae: nature and flavor: bitter, cold.Enter the heart, lung, gallbladder, large intestine channel.The fire of the clear part of the body cavity above the diaphragm housing the heart and lungs of withered person, Expectorant promoting the circulation of QI, relieving asthma and cough, only to lose blood, move back alternate attacks of chills and fever, wind heat is damp and hot.
Radix Paeoniae Rubra: bitter, is slightly cold.Return Liver Channel.Clearing away heat and cooling blood;Blood circulation promoting and blood stasis dispelling.Main maculae caused by violent heat pathogen; Hematemesis and epistaxis;Discharging fresh blood stool;Conjunctival congestion and swelling pain;Carbuncle skin infection;Amenorrhea;Dysmenorrhea;Metrorrhagia and leukorrhagia stranguria with turbid discharge; The stagnant hypochondriac pain of the stasis of blood;Hernia abdominal mass is gathered.
The Radix Aucklandiae: pungent acrid in the mouth;Bitter;Warm in nature.Return spleen;Large intestine, tri-jiao channel.Promoting the circulation of QI to relieve pain;Adjust Middle intestinal stasis relieving.
The function of the present invention and curing mainly: function is replenishing and activating blood, and menstruction regulating and pain relieving cures mainly pelvic cavity Scorching.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described in further details:
Embodiment 1: a kind of Chinese medicine treating pelvic inflammatory disease, including the medicine system of following parts by weight For forming: 15 parts of the Radix Rehmanniae, 3 parts of Poria, Medulla Tetrapanacis 15 parts, Spica Prunellae 4 parts, Radix Scutellariae 20 Part, Radix Paeoniae Rubra 6 parts, the Radix Aucklandiae 10 parts.
Embodiment 2: a kind of Chinese medicine treating pelvic inflammatory disease, including the medicine system of following parts by weight For forming: 30 parts of the Radix Rehmanniae, 8 parts of Poria, Medulla Tetrapanacis 25 parts, Spica Prunellae 7 parts, Radix Scutellariae 30 Part, Radix Paeoniae Rubra 10 parts, the Radix Aucklandiae 15 parts.
Embodiment 3: a kind of Chinese medicine treating pelvic inflammatory disease, including the medicine system of following weight grams For forming: include that the medicine of following parts by weight is prepared from: 26 parts of the Radix Rehmanniae, 6 parts of Poria, Medulla Tetrapanacis 20 parts, Spica Prunellae 6 parts, Radix Scutellariae 25 parts, Radix Paeoniae Rubra 8 parts, the Radix Aucklandiae 13 parts.
Each raw material is mixed by Chinese medicine in embodiment 1-3 in the preparation, by the medicine of its each component Material dry, pulverize into fine powder, and facing-up is uniform, makes the watered pill (every watered pill is containing 0.1 gram of Chinese medicine).
The present invention is not limited to above-mentioned preferred forms, and anyone obtains under the enlightenment of the present invention Go out other any same or like with the present invention as product, all fall within the protection model of the present invention Within enclosing.
The result of clinical observation of the present invention is as follows:
Effective cure rate statistics of the Chinese medicine of the present invention, criterion of therapeutical effect is as follows:
Cure: the transference cures such as lower abdominal pain, heating, vaginal secretions, physical distress discomfort disease Shape disappears.
Effective: etc. symptom alleviated, physical distress malaise symptoms alleviates.
Invalid:: clinical symptoms is without substantially changing.
The present invention treats patient's totally 149 example participating in statistics, wherein: 91 examples of fully recovering, effective 14 Example, no effect 9, total effective rate reaches more than 92%.
Model case:
1, Zhao, female, 32 years old, patient suffered from pelvic inflammation 3 years, treated not through multiple hospitals More, cause patient the most irritated, darkness of mood.Take Chinese medicine preparation of the present invention, take 1 After the course for the treatment of, symptom has disappeared, and after continuing to take 1 course for the treatment of, disease makes moderate progress, and continues Take 2 courses for the treatment of, cure, do not recur so far.
2, Zhang, patient has the symptoms such as leucorrhea abnormal, pudendal pruritus, menoxenia at ordinary times, but The most uncomfortable, pelvic inflammation, after taking this Chinese medicine, clothes is found when doing gynecologial examination After 1 course for the treatment of, Pruritus disappears;After taking 2 courses for the treatment of, leucorrhea is normal;Continue to take 1 After the individual course for the treatment of, fully recover through examination in hospital pelvic inflammation.

Claims (2)

1. the Chinese medicine treating pelvic inflammatory disease, it is characterised in that : it is prepared from by the medicine of following parts by weight: Radix Rehmanniae 15-30 part, Poria 3-8 part, Medulla Tetrapanacis 15-25 part, Spica Prunellae 4-7 part, Radix Scutellariae 20-30 part, Radix Paeoniae Rubra 6-10 part, Radix Aucklandiae 10-15 part.
2. according to a kind of Chinese medicine treating pelvic inflammatory disease described in claim 1, it is characterised in that: it is prepared from by the medicine of following parts by weight: the Radix Rehmanniae 26 parts, 6 parts of Poria, Medulla Tetrapanacis 20 parts, Spica Prunellae 6 parts, Radix Scutellariae 25 parts, Radix Paeoniae Rubra 8 parts, the Radix Aucklandiae 13 parts.
CN201410398490.5A 2014-08-13 2014-08-13 A kind of Chinese medicine treating pelvic inflammatory disease Active CN104116839B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410398490.5A CN104116839B (en) 2014-08-13 2014-08-13 A kind of Chinese medicine treating pelvic inflammatory disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410398490.5A CN104116839B (en) 2014-08-13 2014-08-13 A kind of Chinese medicine treating pelvic inflammatory disease

Publications (2)

Publication Number Publication Date
CN104116839A CN104116839A (en) 2014-10-29
CN104116839B true CN104116839B (en) 2016-08-24

Family

ID=51762619

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410398490.5A Active CN104116839B (en) 2014-08-13 2014-08-13 A kind of Chinese medicine treating pelvic inflammatory disease

Country Status (1)

Country Link
CN (1) CN104116839B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105395996A (en) * 2015-12-03 2016-03-16 刘彩虹 Traditional Chinese medicine preparation for treating pelvic inflammation

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1336219A (en) * 2001-08-21 2002-02-20 徐凤玉 Gynopathy treating traditional Chinese medicine
US20080206155A1 (en) * 2006-11-14 2008-08-28 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
CN101966301A (en) * 2010-07-13 2011-02-09 泰一和浦(北京)中医药研究院有限公司 Chinese medicinal composition for treating pelvic inflammation and preparation method thereof
CN103385964A (en) * 2012-05-13 2013-11-13 闵建华 Method for treating acute pelvic inflammatory disease by using traditional Chinese medicine
CN103536888A (en) * 2013-10-31 2014-01-29 金占荣 Medicine for treating chronic pelvic inflammation and preparation method of same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1336219A (en) * 2001-08-21 2002-02-20 徐凤玉 Gynopathy treating traditional Chinese medicine
US20080206155A1 (en) * 2006-11-14 2008-08-28 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
CN101966301A (en) * 2010-07-13 2011-02-09 泰一和浦(北京)中医药研究院有限公司 Chinese medicinal composition for treating pelvic inflammation and preparation method thereof
CN103385964A (en) * 2012-05-13 2013-11-13 闵建华 Method for treating acute pelvic inflammatory disease by using traditional Chinese medicine
CN103536888A (en) * 2013-10-31 2014-01-29 金占荣 Medicine for treating chronic pelvic inflammation and preparation method of same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
几种通草及小通草的抗炎、解热、利尿作用的实验研究;沈映君等;《中国中药杂志》;19981231;第23卷(第11期);第687、690、704页,尤其是第687页摘要,左栏第1段 *
李光荣教授运用活血药治疗妇科癥瘕经验;刘新敏;《中华中医药杂志》;20110430;第26卷(第4期);第733-735页,尤其是第735页左栏第1段 *

Also Published As

Publication number Publication date
CN104116839A (en) 2014-10-29

Similar Documents

Publication Publication Date Title
CN103536888A (en) Medicine for treating chronic pelvic inflammation and preparation method of same
CN103520530B (en) Medicament for treating erysipelas and preparation method thereof
CN103735889B (en) A kind of medicine for the treatment of pyelonephritis and preparation method thereof
CN104116839B (en) A kind of Chinese medicine treating pelvic inflammatory disease
CN103007093A (en) Medicine for treating gynecological inflammation and preparation method thereof
CN104173897B (en) Treat the Chinese medicine composition of the menopausal syndrome as caused by ovarian failure
CN106215065A (en) One is used for treating colpitic Chinese medicine composition and preparation method thereof
CN103127376B (en) Chinese medicine composition capable of curing proctitis
CN103977168A (en) Traditional Chinese medicine preparation for treating pulmonary emphysema
CN106880814A (en) A kind of Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof
CN104906449A (en) Traditional Chinese medicine for treating cervicitis
CN104800435A (en) Traditional Chinese medicine formula for treating chronic pelvic inflammatory disease
CN104399030A (en) Traditional Chinese medicine for treatment of uterine leiomyoma
CN104258181A (en) Traditional Chinese medicine preparation for treating acute urticaria
CN107519456A (en) A kind of decoction medicine for treating pelvic infecton and preparation method thereof
CN108653628A (en) A kind of Chinese medicine composition and preparation method thereof for treating chronic cervicitis
CN107582971A (en) A kind of pill medicine and preparation method for treating pelvic infecton
CN107551225A (en) A kind of pill medicine and preparation method for treating pelvic infecton
CN107519459A (en) It is a kind of effectively to treat Chinese medicine composition of palace cold and preparation method thereof
CN107343948A (en) It is a kind of effectively to treat pill medicine of hepatitis B and preparation method thereof
CN107375738A (en) A kind of Chinese medicine composition for treating ITP blood-head disease
CN105381347A (en) Traditional Chinese medicine for treating pelvic inflammation
CN107684587A (en) It is a kind of effectively to treat endo-medicine of pelvic infecton and preparation method thereof
CN108126136A (en) A kind of capsule medicine and preparation method for treating chronic pelvic inflammatory disease
CN107496827A (en) It is a kind of effectively to treat pill medicine of fibroid and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C41 Transfer of patent application or patent right or utility model
CB03 Change of inventor or designer information

Inventor after: Liu Xuemei

Inventor after: Wang Lizhong

Inventor after: Zhang Min

Inventor before: Jin Xianqi

COR Change of bibliographic data
TA01 Transfer of patent application right

Effective date of registration: 20160712

Address after: 266300 obstetrics and Gynecology, Jiaozhou Central Hospital, Xuzhou Road, Jiaozhou 29, Shandong, Qingdao, Qingdao

Applicant after: Liu Xuemei

Address before: 467000 Department of pharmacy, Pingdingshan First People's Hospital, Weidong District, Henan, Pingdingshan

Applicant before: Jin Xianqi

C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20200904

Address after: 233000 Room 1402, Ziyang Building, Pearl Plaza, Huaishang District, Bengbu City, Anhui Province

Patentee after: Bengbu HRABERO Intellectual Property Service Co.,Ltd.

Address before: 266300 obstetrics and Gynecology, Jiaozhou Central Hospital, Xuzhou Road, Jiaozhou 29, Shandong, Qingdao, Qingdao

Patentee before: Liu Xuemei

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20200923

Address after: No.10, Weihai Road, concentrated district, Heping Road, economic development zone, Harbin, Heilongjiang Province

Patentee after: Heilongjiang Tianchen Pharmaceutical Co.,Ltd.

Address before: 233000 Room 1402, Ziyang Building, Pearl Plaza, Huaishang District, Bengbu City, Anhui Province

Patentee before: Bengbu HRABERO Intellectual Property Service Co.,Ltd.